16281922

Source:http://linkedlifedata.com/resource/pubmed/id/16281922

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0015980, umls-concept:C0019721, umls-concept:C0026769, umls-concept:C0456387, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	6
pubmed:dateCreated	2005-11-11
pubmed:abstractText	To study the relationship between human leucocyte antigen (HLA) genotype and clinical response to interferon-beta (IFN-beta).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370336
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta, http://linkedlifedata.com/resource/pubmed/chemical/interferon beta 1a, http://linkedlifedata.com/resource/pubmed/chemical/interferon beta-1b
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0001-6314
pubmed:author	pubmed-author:AlonsoAA, pubmed-author:FernándezOO, pubmed-author:FernándezVV, pubmed-author:GuerreroMM, pubmed-author:LeónAA, pubmed-author:LeyvaLL, pubmed-author:LuqueGG, pubmed-author:MayorgaCC, pubmed-author:RomeroFF, pubmed-author:TakaraNN, pubmed-author:de RamónEE
pubmed:issnType	Print
pubmed:volume	112
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	391-4
pubmed:dateRevised	2006-8-16
pubmed:meshHeading	pubmed-meshheading:16281922-Adult, pubmed-meshheading:16281922-Alleles, pubmed-meshheading:16281922-Cohort Studies, pubmed-meshheading:16281922-Disability Evaluation, pubmed-meshheading:16281922-Disease Progression, pubmed-meshheading:16281922-Dose-Response Relationship, Drug, pubmed-meshheading:16281922-Drug Administration Schedule, pubmed-meshheading:16281922-Female, pubmed-meshheading:16281922-Gene Frequency, pubmed-meshheading:16281922-Genotype, pubmed-meshheading:16281922-Histocompatibility Antigens Class II, pubmed-meshheading:16281922-Humans, pubmed-meshheading:16281922-Injections, Intramuscular, pubmed-meshheading:16281922-Injections, Subcutaneous, pubmed-meshheading:16281922-Interferon-beta, pubmed-meshheading:16281922-Male, pubmed-meshheading:16281922-Middle Aged, pubmed-meshheading:16281922-Multiple Sclerosis, pubmed-meshheading:16281922-Neurologic Examination, pubmed-meshheading:16281922-Prospective Studies, pubmed-meshheading:16281922-Treatment Outcome
pubmed:year	2005
pubmed:articleTitle	HLA class II and response to interferon-beta in multiple sclerosis.
pubmed:affiliation	Institute of Clinical Neurosciences, Hospital Regional Universitario Carlos Haya, Málaga, Spain. oscar.fernandez.sspa@juntadeandalucia.es
pubmed:publicationType	Journal Article